Losartan and nsaids
Pro Research Analysisby 
Searched over 200M research papers
Losartan and NSAIDs: Interactions and Protective Effects
Impact of NSAIDs on Losartan's Antihypertensive Efficacy
Indomethacin and Blood Pressure Control
Nonsteroidal anti-inflammatory drugs (NSAIDs) are known to interfere with the efficacy of various antihypertensive medications. A study investigated the effect of indomethacin, a common NSAID, on the blood pressure-lowering capabilities of losartan, an angiotensin II receptor antagonist, and captopril, an angiotensin-converting enzyme inhibitor (ACEI). The study found that both losartan and captopril significantly reduced ambulatory diastolic blood pressure after six weeks of treatment. However, the addition of indomethacin attenuated this effect in both medications. Specifically, indomethacin increased the 24-hour ambulatory diastolic blood pressure by 2.2 mm Hg in patients treated with losartan and by 2.7 mm Hg in those treated with captopril . This suggests that concurrent use of indomethacin can diminish the antihypertensive efficacy of losartan.
Gastroprotective Effects of Losartan Against NSAID-Induced Injury
Losartan and Aspirin-Induced Gastric Mucosal Injury
NSAIDs, including aspirin, are known to cause gastric mucosal injury, leading to ulcers. Research has shown that angiotensin receptor blockers (ARBs) like losartan may offer protective effects against such injuries. In a study involving rats, losartan was found to mitigate the harmful effects of aspirin on the gastric mucosa. The study demonstrated that pretreatment with losartan significantly reduced the severity of aspirin-induced gastric ulcers. This protective effect was attributed to losartan's ability to maintain higher levels of gastric prostaglandin E2 (PGE2), superoxide dismutase (SOD), nitric oxide (NO), and catalase (CAT) . Notably, losartan was more effective than enalapril, an ACEI, in increasing CAT activity, which plays a crucial role in protecting the gastric mucosa from oxidative stress .
Conclusion
The interaction between losartan and NSAIDs, particularly indomethacin, can reduce the antihypertensive efficacy of losartan, highlighting the need for careful management of patients requiring both medications. On the other hand, losartan shows promise in protecting against NSAID-induced gastric mucosal injury, making it a potentially valuable option for patients at risk of peptic ulcers due to NSAID use. These findings underscore the importance of considering both the benefits and drawbacks of combining losartan with NSAIDs in clinical practice.
Sources and full results
Most relevant research papers on this topic
DOI